Carl Zeiss Meditec AG

AFX

Equity

ISIN DE0005313704 / Valor 1055489

Xetra (2026-02-26)

EUR 27.28+3.10%

Carl Zeiss Meditec AG
UMushroom community rating:

4.40 5 votes No rating yet

NegativeNeutralPositive

About company

Carl Zeiss Meditec AG, headquartered in Jena, Germany and listed on the Frankfurt Stock Exchange, is a medical-technology company focused principally on devices, software and consumables for eye care and microsurgery. Its product portfolio spans diagnostic imaging systems (including optical coherence tomography and retinal imaging), surgical platforms and visualization equipment (such as surgical microscopes and laser systems for refractive and cataract procedures), as well as intraocular lenses, disposables and clinical IT solutions that support workflow and data management. The company sells capital equipment to hospitals, eye clinics and private practices worldwide and generates recurring revenue from consumables, service contracts and software, while investing in research and regulatory approvals to maintain and extend its market position in ophthalmology and related microsurgical fields.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-53.2%1Y

-79.1%3Y

-78.1%5Y

Performance

48.3%1Y

42.2%3Y

39.8%5Y

Volatility

2818 M

Market cap (USD)

237,912

Daily traded volume (Shares)

47.3 / 46.28

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.40

5 votes

Performance:

4.20

Innovation:

4.80

Society:

4.40

Nature:

4.20

Luba Schoenig

Switzerland, 08 Jun 2023

Highly innovative company who is expected to be one of the key riders on the virtual reality glasses wave

Tonia Zimmermann

Switzerland, 06 Jun 2023

Big potential ahead of them given the use of their solutions in apple products

Laura Bischofberger

Switzerland, 06 Jun 2023

Interessante Performance über die letzten Jahre. & mit der Vorstellung vom neuen Produkt gestern durch Apple, ist ein gross Auftrag garantiert

EQUITIES OF THE SAME SECTOR

Helen of Troy Ltd

Helen of Troy Ltd Valor: 938381

Annual Return

-50%0%+50%

Risk level

110

-0.41%USD 16.92

ImmunityBio Inc

ImmunityBio Inc Valor: 110468647

Annual Return

-50%0%+50%

Risk level

110

-17.40%USD 9.54

Alignment Healthcare Inc

Alignment Healthcare Inc Valor: 110387702

Annual Return

-50%0%+50%

Risk level

110

2.70%USD 20.13

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB Valor: 2676862

Annual Return

-50%0%+50%

Risk level

110

-1.29%SEK 399.40

Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc Valor: 25337263

Annual Return

-50%0%+50%

Risk level

110

0.51%USD 99.15

Elekta AB

Elekta AB Valor: 613625

Annual Return

-50%0%+50%

Risk level

110

1.23%SEK 57.65

Janux Therapeutics Inc

Janux Therapeutics Inc Valor: 111742522

Annual Return

-50%0%+50%

Risk level

110

0.37%USD 13.70

M1 Kliniken AG

M1 Kliniken AG Valor: 29694419

Annual Return

-50%0%+50%

Risk level

110

2.37%EUR 16.40

Lineage Inc

Lineage Inc Valor: 136372357

Annual Return

-50%0%+50%

Risk level

110

6.28%USD 40.45

AstraZeneca PLC

AstraZeneca PLC Valor: 982352

Annual Return

-50%0%+50%

Risk level

110

-0.70%GBP 152.18

Logos provided by Clearbit

Carl Zeiss Meditec AG

AFX

ISIN DE0005313704 / Valor 1055489

Carl Zeiss Meditec AG UMushroom community rating:

Luba Schoenig

Tonia Zimmermann

Laura Bischofberger

Carl Zeiss Meditec AG
UMushroom community rating: